Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Capital Expenditures
Abbott Laboratories
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Capital Expenditures
-$2.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Capital Expenditures
-$782m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Capital Expenditures
-$711m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Capital Expenditures
-$266.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
Stryker Corp
NYSE:SYK
|
Capital Expenditures
-$575m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-11%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Capital Expenditures
-$1.1B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-26%
|
See Also
What is Abbott Laboratories's Capital Expenditures?
Capital Expenditures
-2.2B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Capital Expenditures amounts to -2.2B USD.
What is Abbott Laboratories's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-7%
Over the last year, the Capital Expenditures growth was -20%.